Retinal and neural cell membrane phospholipids

Retinal and neural cell membrane phospholipids are essential structural components of the lipid bilayer in neurons and retinal cells (PubMed PMID: 21961463). They play a critical role in maintaining membrane integrity, fluidity, and the proper functioning of membrane-bound proteins, including ion channels, transporters, and receptors (PubMed PMID: 12471251). These phospholipids, such as phosphatidylcholine and phosphatidylethanolamine, are vital for signal transduction and the protection of cells from oxidative damage. In various pathological conditions like ischemic stroke, glaucoma, and neurodegenerative diseases, the degradation of these phospholipids leads to membrane dysfunction and cell death (PubMed PMID: 25642984). Therapeutic agents like citicoline act as precursors to stimulate the synthesis of these phospholipids, thereby promoting neurorepair and neuroprotection (DrugBank DB01215). By restoring the phospholipid composition of the membrane, these drugs help stabilize cell membranes and improve neuronal and retinal function. Additionally, polyunsaturated fatty acids like docosahexaenoic acid (DHA) are incorporated into these membranes to support visual and cognitive health. The maintenance of these phospholipids is crucial for the survival of retinal ganglion cells and the prevention of neurodegeneration (PubMed PMID: 21113631).

Other names

Neuronal membrane phospholipidsRetinal phospholipidsMembrane phospholipidsStructural phospholipids

Drugs targeting these phospholipids typically act as precursors to stimulate their biosynthesis, thereby restoring membrane integrity, improving the function of membrane-bound ion pumps and receptors, and providing neuroprotection against oxidative stress and ischemia (DrugBank DB01215; StatPearls).